Malignant tumors
Malignant tumors, commonly referred to as cancers, are characterized by their ability to invade surrounding tissues and spread to other parts of the body via the bloodstream or lymphatic system. These tumors consist of abnormal cells that often appear larger and irregular in shape compared to normal cells. They are classified based on their tissue of origin, with terms such as sarcoma for connective tissue cancers and carcinoma for those originating from epithelial tissue. Risk factors associated with malignant tumors include tobacco use, exposure to ultraviolet and ionizing radiation, certain chemicals, viral infections, and family history.
The development of malignant tumors is marked by mutations in cells that allow them to replicate uncontrollably, often leading to a compromised immune response. Symptoms may vary but can include unusual bleeding, persistent coughs, unexplained weight loss, and changes in existing skin lesions. Diagnosis typically involves imaging techniques like X-rays, MRIs, and CT scans, along with blood tests for tumor markers. Treatment options are diverse and may include surgery, radiation, chemotherapy, hormone therapy, or newer approaches like mRNA vaccines and targeted therapies. Preventative measures such as maintaining a healthy lifestyle and minimizing exposure to harmful substances are crucial in the fight against cancer.
On this Page
Malignant tumors
ALSO KNOWN AS: Cancerous tumors
RELATED CONDITIONS: Most cancers
DEFINITION: Malignant tumors are those that invade surrounding tissue. Commonly known as cancer, cells of tumors are abnormal in morphology, tend to be larger than normal, and have odd shapes and large and irregular nuclei. By entering into the bloodstream or the lymphatic system, these cells spread to surrounding tissue, where they damage the tissues and organs. A sarcoma is a cancer of the connective tissue, and carcinomas are of epithelial origin. Malignant tumors are named using the Latin or Greek root of the organ of origin as a prefix and “sarcoma” or “carcinoma” as the suffix. For example, a malignant tumor of the liver is called hepatocarcinoma; a malignant tumor of the fat cells is called liposarcoma.
Risk factors: The most common risk factors for the development of malignant tumors include tobacco use, exposure to ultraviolet (UV) radiation, ionizing radiation, certain chemicals, and viruses, and family history.
Etiology and the disease process: A mutated cell that continues to divide is a hallmark of cancer. The deoxyribonucleic acid (DNA) repair mechanisms are damaged, and the immune system is compromised such that the tumor cells rapidly multiply undeterred. Additionally, the tumor has an extensive vasculature that provides nutrients and oxygen for its growth.
Symptoms: Unusual bleeding or discharge, a change in the shape or coloration of a wart or mole, a sore throat that does not heal, unexplained weight loss, persistent cough, and anemia are some warning signs. Many symptoms are caused by the fatigue, pain, and stress imposed on the body by malignant tumors.
Screening and diagnosis: X-rays, ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT) scans are used to detect changes in tissues or organs, and blood tests are used to monitor abnormal cell counts. Presence of tumor markers such as prostate specific (PSA), carcinoembryonic antigen (CEA), and human chorionic gonadotropin hormone in the blood are used to screen high-risk individuals.
Treatment and therapy: Malignant tumors can be removed before they (spread), but frequently they grow back. Besides a person’s age, general health, and response to treatment, the outcome depends on the type and location of the cancer, the stage of the disease (the extent to which the cancer has spread), or its grade (how abnormal the cancer cells look and how quickly the cancer is likely to grow and spread). Treatment includes surgery, radiation therapy, chemotherapy, hormone therapy, or biological therapy. However, most often a combination of therapies is required for complete eradication of the malignancy. Choice of a healthy, active, tobacco-free lifestyle with a minimum exposure to harmful UV rays can go a long way in preventing cancer.
In the twenty-first century, treatment options for malignant tumors continued to expand. In treating malignant brain tumors, mRNA vaccines can reprogram the patient’s immune system to attack cancer cells. Targeted therapies that attack specific cancers, such as Dual-Target Car T Cell Therapy, are helping to shrink tumors in patients with particular brain cancers.
Bibliography
Baykal, Can, and K. Didem Yazganoglu. Clinical Atlas of Skin Tumors. New York: Springer, 2014.
Bloch, Orin, and Franco DeMonte, eds. Neurosurgery Clinics of North America: Malignant Tumors of the Skull Base, vol. 24.1, 2013, pp. 1–142.
Bonar, Samantha. “5 Oncology Breakthroughs to Be Excited About in 2022.” City of Hope, 23 Dec. 2021, www.cityofhope.org/breakthroughs/5-oncology-breakthroughs-to-be-excited-about-in-2022. Accessed 14 June 2024.
Fletcher, Christopher D. M. Diagnostic Histopathology of Tumors. 4th ed. Philadelphia: Saunders-Elsevier, 2013.
Gomez, Dhanwant, and Dileep N. Lobo. "Malignant Liver Tumours." Surgery, vol. 29.12, 2011, pp. 632–39.
Kaye, Andrew H., and Edward R. Laws, Jr. Brain Tumors: An Encyclopedic Approach. 3rd ed. New York: Saunders-Elsevier, 2012.
“Tumor: What Is It, Types, Symptoms, Treatment & Prevention.” Cleveland Clinic, 5 Oct. 2021, my.clevelandclinic.org/health/diseases/21881-tumor. Accessed 14 June 2024.